Calamos Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Calamos Advisors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-192,524	Closed	-$3.03M	–	1568
2022 Q2	$3.03M	Sell	192,524 -2,476	-1%	-$37.8K	0.01%	834
2022 Q1	$2.97M	Hold	195,000	–	–	0.01%	842
2021 Q4	$3M	Buy	+195,000	New	+$2.57M	0.01%	823

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Calamos Advisors's NPTN Position: Q3 2022 in Review

Calamos Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 192,524 shares — an estimated $3.03M sold.

Calamos Advisors first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $3.03M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Calamos Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Calamos Advisors sold 192,524 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3.03M.
Calamos Advisors first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
Calamos Advisors's NEOPHOTONICS CORP position peaked at $3.03M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.